Widely used in peptide synthesis and medicinal chemistry as a protected chiral building block. The fluorenylmethyloxycarbonyl (Fmoc) group enables reversible amine protection, compatible with solid-phase synthesis strategies. The difluorinated pyrrolidine core enhances metabolic stability and modulates conformational rigidity in bioactive molecules. Frequently employed in the development of protease inhibitors and other pharmaceuticals where stereochemistry and fluorination impact potency and pharmacokinetics. Its structure supports high diastereoselectivity in coupling reactions, making it valuable for synthesizing complex drug candidates.